Tag Archives: Federal Circuit

Allergan V. Sandoz – When Everything “Old” Is “New” Again

Posted on May 2, 2013 by Warren Woessner

On Tuesday, a divided panel of the Fed. Cir. found that Allergan’s claimed method of reducing the number of daily topical doses of brimonidine to treat glaucoma from 3 to 2 doses by administering a composition containing 0.2% brimonidine and … Continue reading →

Posted in Inherency | Tagged , , , , , , , , | Leave a comment

Saffran v. J&J – When Defining Equals Disclaiming

Posted on April 17, 2013 by Warren Woessner

A guest post from Theresa Stadheim of Schwegman Lundberg & Woessner, P.A. In Bruce N. Saffran, M.D., Ph.D., v. Johnson & Johnson and Cordis Corporation, Appeal No. 2012-1043 (Fed. Cir. April 4, 2013, decision by Lourie), the Federal Circuit reversed … Continue reading →

Posted in Claim Interpretation | Tagged , , , , , , , | Leave a comment

Federal Court Affirms BPAI in Dawson v. Dawson and Bowman

Posted on March 27, 2013 by Warren Woessner

This is a guest post from Theresa Stadheim of Schwegman Lundberg & Woessner In Chandler Dawson v. Chandler Dawson and Lyle Bowman, Appeal Nos. 2012-1214,-1215,-1216, -1217 (Fed. Cir. March 25, 2013) (a copy can be found at the end of … Continue reading →

Posted in Inventorship | Tagged , , , , , , , , , , , | Leave a comment

Patents4Life is Four Years Old

Posted on March 26, 2013 by Warren Woessner

On March 24th, Patents4Life forgot to celebrate its 4th anniversary. On March 24, 2009, I started the blog (or is it “blawg”) by posting three articles on fairly recent Fed. Cir. decisions. One of the articles discussed the application of … Continue reading →

Posted in Miscellaneous | Tagged , , , , , | 1 Comment